MGS, a provider of end-to-end healthcare solutions, has launched the A.i.r. Platform, a customizable auto-injector platform ...

Harald Hampel is recognized as an influential leader in neuroscience, and will bring expertise in Alzheimer's disease to BMS.

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

Immunai, an AI biotech company specializing in mapping the human immune system, has announced a strategic collaboration with ...

Zydus Lifesciences Limited, an innovation-led life-sciences company with an international presence, has closed its ...

Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, has appointed David ...

The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

Vetter, a globally operating CDMO, has completed several important steps in the ongoing development and upcoming launch of V-OVS® next.

The pact boosts Rakuten’s production capabilities for photoimmunotherapy in oncology, with LOTTE providing advanced ...

Fresenius Kabi and TQ Therapeutics, have entered into a strategic-development agreement under which Fresenius Kabi has an ...

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...

Symeres has announced the appointment of Jurgen Berendsen as Chief Financial Officer (CFO), marking a return to the company ...